Johnson & Johnson (JNJ) is taking steps to ensure Sirturo, its medicine for people with drug-resistant tuberculosis, is available and properly administered in 130 developing countries across the globe. The tablet was approved by the U.S. Food and Drug Administration in 2012 as the first new medicine in 40 years to treat the contagious lung infection. It’s recommended by the World Health Organization for use in combination with other drugs to treat those most in danger from the disease. Yet it’s still not approved or affordable in most countries.
Help employers find you! Check out all the jobs and post your resume.
